Cidara Therapeutics, Inc. (NASDAQ:CDTX) Q1 2025 Earnings Call Transcript May 8, 2025
Cidara Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.66, expectations were $-5.45.
Operator: Earlier this afternoon, Cidara Therapeutics, Inc. released financial results and a business update for the first quarter ended March 31, 2025. A copy of the press release and corporate presentation are available on the company’s website. Please note that certain information discussed on the call...
